6534 logo

CH Biotech R&D Co., Ltd. Stock Price

TWSE:6534 Community·NT$9.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6534 Share Price Performance

NT$91.30
19.30 (26.81%)
NT$91.30
19.30 (26.81%)
Price NT$91.30

6534 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

1 Risk
1 Reward

CH Biotech R&D Co., Ltd. Key Details

NT$1.8b

Revenue

NT$292.4m

Cost of Revenue

NT$1.5b

Gross Profit

NT$1.1b

Other Expenses

NT$464.0m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
4.51
83.93%
25.51%
18.8%
View Full Analysis

About 6534

Founded
2013
Employees
n/a
CEO
Wen Ren Chen
WebsiteView website
www.chbio.com

CH Biotech R&D Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of agriculture chemicals in Taiwan, the United States, and internationally. It offers fertilizers, biostimulants, and plant growth regulators; and provides biotechnology services. The company was incorporated in 2013 and is headquartered in Nantou City, Taiwan.

Recent 6534 News & Updates

Recent updates

No updates